Sutro Biopharma Inc
NASDAQ:STRO

Watchlist Manager
Sutro Biopharma Inc Logo
Sutro Biopharma Inc
NASDAQ:STRO
Watchlist
Price: 2.51 USD -0.79% Market Closed
Market Cap: 205.7m USD
Have any thoughts about
Sutro Biopharma Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Sutro Biopharma Inc

Current Assets 405.8m
Cash & Short-Term Investments 388.3m
Receivables 6.7m
Other Current Assets 10.9m
Non-Current Assets 46.1m
PP&E 38m
Other Non-Current Assets 8m
Current Liabilities 131.3m
Accounts Payable 6.2m
Accrued Liabilities 52.5m
Other Current Liabilities 72.6m
Non-Current Liabilities 209.3m
Other Non-Current Liabilities 209.3m

Balance Sheet
Sutro Biopharma Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
12
22
125
5
206
30
47
69
Cash Equivalents
12
22
125
5
206
30
47
69
Short-Term Investments
36
0
79
113
162
168
287
306
Total Receivables
1
2
3
6
6
13
7
36
Accounts Receivables
1
2
3
6
6
13
7
36
Other Receivables
0
0
0
0
0
0
0
0
Other Current Assets
2
2
3
4
5
8
12
10
Total Current Assets
50
26
210
129
378
219
353
422
PP&E Net
19
14
11
10
13
52
51
45
PP&E Gross
19
14
11
10
13
52
51
45
Accumulated Depreciation
20
25
29
34
37
33
38
42
Long-Term Investments
0
0
0
16
0
69
0
0
Other Long-Term Assets
1
1
2
3
3
3
3
4
Total Assets
69
N/A
41
-41%
223
+447%
156
-30%
394
+152%
341
-13%
407
+19%
471
+16%
Liabilities
Accounts Payable
3
3
3
6
6
11
5
9
Accrued Liabilities
3
4
6
6
9
13
33
60
Short-Term Debt
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
15
5
1
0
9
13
4
Other Current Liabilities
44
11
22
20
15
9
17
21
Total Current Liabilities
50
32
36
33
30
42
67
94
Long-Term Debt
1
2
10
9
25
16
4
0
Other Liabilities
6
14
45
17
8
31
120
227
Total Liabilities
58
N/A
47
-18%
92
+94%
59
-36%
62
+6%
89
+43%
190
+114%
321
+69%
Equity
Common Stock
103
103
0
0
0
0
0
0
Retained Earnings
95
115
150
196
228
333
453
559
Additional Paid In Capital
5
6
282
293
560
586
670
709
Other Equity
0
0
0
0
0
0
1
0
Total Equity
12
N/A
7
N/A
132
N/A
98
-26%
332
+239%
253
-24%
217
-14%
150
-31%
Total Liabilities & Equity
69
N/A
41
-41%
223
+447%
156
-30%
394
+152%
341
-13%
407
+19%
471
+16%
Shares Outstanding
Common Shares Outstanding
22
22
23
23
46
46
58
61

See Also

Discover More